Effect of Dexmedetomidine Versus Dexamethasone as Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Plane Block on Postoperative Analgesia in Myasthenic Patients Undergoing Thoracoscopic Thymectomy
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This current comparative study involved 54 patients undergoing thoracoscopic thymectomy who were distributed randomly into three equal groups to receive ultrasound (US)-guided ESPB using 20 ml bupivacaine 0.25% (group B) , 20 ml bupivacaine 0.25% with 8 mg dexamethasone (group BS), 20 ml bupivacaine 0.25% with dexmedetomidine 1mcg/kg (group BM). The time till the first postoperative rescue analgesic requested was the primary outcome. The secondary outcomes included the postoperative pain scores and analgesic consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2026
CompletedFirst Posted
Study publicly available on registry
February 20, 2026
CompletedStudy Start
First participant enrolled
March 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 15, 2026
February 20, 2026
February 1, 2026
6 months
February 15, 2026
February 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
the duration between the surgery end and the 1st rescue analgesia the patient requested.
24 hours postoperatively
Secondary Outcomes (2)
.Total ketorolac consumption
24 hours postoperatively
. Number of patients needed rescue tramadol
24 hours postoperatively
Study Arms (3)
(group B)
ACTIVE COMPARATORultrasound (US)-guided ESPB using 20 ml bupivacaine 0.25%
Group BS
ACTIVE COMPARATOR20 ml bupivacaine 0.25% with 8 mg dexamethasone
Group BM
ACTIVE COMPARATOR20 ml bupivacaine 0.25% with dexmedetomidine 1mcg/kg
Interventions
An echogenic 21 gauge 10 cm needle was introduced in caudo-cephalic orientation utilizing the in-plane approach and traversing through trapezius, rhomboid, and erector spinae muscles till reaching the transverse process then slightly withdrawn and hydrodissection was done by 3 mL of saline 0.9% to verify the accurate implantation of the block needle tip between the erector spinae muscle and the transverse process (the erector spinae plane). Incremental LA injection was verified through US observation for the upward displacement and lifting of erector spinae muscle from the transverse process with craniocaudal spread of the LA in the targeted plane. The LA increments were one ml every 5 seconds with intermittent aspiration every 5 mL to avoid intravascular injection.
Eligibility Criteria
You may qualify if:
- myasthenic patients
- American Society of Anesthesiologists (ASA) physical grade of 2-3)
- who underwent video assisted thoracoscopic thymectomy
You may not qualify if:
- Refused participation in the study,
- known allergy for this study drugs ,
- Contraindication to the ESPB as infection at block site \& marked chest cage deformity,
- significant bleeding disorders ,
- patients with significant renal or liver dysfunction,
- heart block ,
- poor ventilatory function,
- severe chronic obstructive pulmonary disease,
- morbid obesity,
- mental disability, or communication difficulties that hindered effective pain assessment,
- Individuals who was converted to open thoracotomy or those re-explorated for surgical related issues.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assisstant professor of anesthesia,intensive care and pain management
Study Record Dates
First Submitted
February 15, 2026
First Posted
February 20, 2026
Study Start
March 15, 2026
Primary Completion (Estimated)
September 15, 2026
Study Completion (Estimated)
September 15, 2026
Last Updated
February 20, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share